Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Kyprolis Chemotherapy Information

If you have multiple myeloma, a type of cancer that affects certain white blood cells, your healthcare provider may prescribe KyprolisTM (carfilzomib). However, because this chemotherapy drug is not suitable for everyone, it's important to review the safety information for Kyprolis with your healthcare provider before starting treatment. For example, make sure your healthcare provider is aware of any other health issues you may have, such as kidney disease, heart problems, or any allergies.
 
Kyprolis is given slowly into a vein (intravenously, or by IV) once a day for two consecutive days every seven days. After the sixth dose, you will have a 12-day break in treatment. The drug is given by a healthcare provider in a healthcare setting and works to destroy cancer cells.
 
Most people who receive Kyprolis will experience some type of side effect. Some of the most common problems include fatigue, nausea, and anemia.
 
(Click Kyprolis for more information on this chemotherapy drug, including safety warnings, how it works, dosing guidelines, and more.)
 
 

Kyprolis Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.